Latest Announcements

Trading in JB Chemicals & Pharmaceuticals Limited's equity shares has been suspended on the NSE, effective July 17, 2026, due to a Scheme of Amalgamation.

Emcure Pharmaceuticals Limited has consolidated its shareholding in biopharma subsidiary Gennova Biopharmaceuticals Limited, acquiring the entire 12.05% minority stake held by Dr. Sanjay Singh and others, making Gennova a wholly owned subsidiary. Gennova will be led by Mr. Samit Mehta and will focus on its biologics franchise, biosimilars development, and adjacent therapeutic platforms.

NIIT Learning Systems Limited recognized as a market leader in 2026 Fosway's AI Market Assessment for Digital Learning, leading the market on live AI delivery.

Aster DM Healthcare Limited has informed the Exchange about allotment of equity shares to the shareholders of transferor Company (QCIL) pursuant to the scheme of Amalgamation.

Emcure Pharmaceuticals Limited has acquired 12.05% stake in its subsidiary Gennova Biopharmaceuticals Limited for Rs. 2,318.7 million.

DiGiSPICE Technologies Limited held a shareholders meeting on July 13, 2026, as per the order of the Hon'ble National Company Law Tribunal (Principal Bench, New Delhi). The meeting was held through video conferencing and considered a resolution to approve the Scheme of Amalgamation by way of merger between Spice Money Limited, E-Arth Travel Solutions Private Limited, Vikasni Fintech Private Limited, and DiGiSPICE Technologies Limited.

Somany Ceramics Limited's Board of Directors has approved an investment of up to Rs. 58.80 crore in Siravit Ceramics Private Limited, up to Rs. 2.00 crore in V.S. Industries Private Limited, and up to Rs. 15.00 crore in Sudha Somany Ceramics Private Limited.

Somany Ceramics Limited has approved in-principle investments in M/s. Siravit Ceramics Private Limited and M/s. V.S. Industries Private Limited, with the former to be up to Rs. 58.80 crore and the latter up to Rs. 2.00 crore. The investments are subject to regulatory approvals and will result in the company acquiring up to 49% and 50% of the equity share capital of the respective entities.

Somany Ceramics Limited has approved an investment of up to Rs. 58.80 crore in M/s. Siravit Ceramics Private Limited, a company that manufactures glazed vitrified tiles, to acquire up to 49% of its share capital. The investment will be made in one or more tranches and is expected to be completed within approximately 90 days.

Somany Ceramics Limited's board has approved an investment of up to Rs. 58.80 crore in M/s. Siravit Ceramics Private Limited and up to Rs. 2.00 crore in M/s. V.S. Industries Private Limited, and an additional investment of up to Rs. 15.00 crore in M/s. Sudha Somany Ceramics Private Limited.

Creative Newtech Limited has announced a proposed acquisition of Infinova (India) Private Limited to build a 'Make in India' surveillance technology platform. The acquisition includes Infinova's business operations in India, exclusive brand rights, technical assistance, existing experienced team, product assembly and manufacturing facility. The transaction is subject to satisfactory due diligence, necessary approvals, and execution of definitive agreements.

Creative Newtech Limited proposes to acquire Infinova (India) Private Limited to build a Make in India Surveillance Technology Platform. The acquisition includes Infinova's business operations in India, exclusive brand rights, technical assistance, existing experienced team, product assembly and manufacturing facility. The proposed acquisition is subject to satisfactory due diligence, necessary approvals and execution of definitive agreements.

Creative Newtech Limited has informed the Exchange regarding Outcome of Board Meeting held on July 13, 2026, where the Board of Directors approved the proposed acquisition of 100% of the equity share capital of Infinova (India) Private Limited for up to USD 4.00 Million.

Tata Capital Limited has informed the Exchange regarding a press release dated July 13, 2026, titled "Tata Capital limited Enters Gold Loans Through Acquisition of Yogloans". The Board of Directors has approved the execution, delivery and performance of a Securities Subscription and Purchase Agreement between Tata Capital Limited, Yogakshemam Loans Limited and its sellers. The acquisition is aligned with the Company's strategy of expanding and diversifying its retail lending portfolio in India and provides access to an established gold loan platform with an existing branch network, customer franchise and experienced management team.

Tata Capital Limited has informed the Exchange regarding Disclosure under Regulation 30 of SEBI Listing Regulations with respect to acquisition of Yogakshemam Loans Limited.

TVS Supply Chain Solutions Limited has received approval from the National Company Law Tribunal for the Scheme of Amalgamation of Mahogany Logistics Services Private Limited, TVS SCS Global Freight Solutions Limited, White Data Systems India Private Limited, and FLEXOL Packaging (India) Limited with TVS Supply Chain Solutions Limited. The scheme will be effective from April 1, 2023, subject to the sanction of the Scheme by the Hon'ble NCLT, Bengaluru Bench and filing of the certified order copies by all the Companies of the respective orders of the jurisdictional NCLT sanctioning the Scheme with the jurisdictional Registrar of Companies.

Amber Enterprises India Limited's material subsidiary IL JIN Electronics (India) Private Limited has approved key matters, including share capital alteration, bonus share issuance, and conversion to a public limited company.

Mankind Pharma Limited has informed the Exchange about the acquisition of 100% stake in Broadway Hospitality Services Private Limited and the incorporation of a wholly owned subsidiary company in Netherlands to act as a Special Purpose Vehicle for holding investments in R&D assets and business development activities focused on treatment of niche therapies.

Orchid Pharma Limited has informed the Exchange that the Record date for the purpose of Merger/HiveOff is 23-Jul-2026.

Orchid Pharma Limited has informed the Exchange regarding the Amendment to AOA/MOA of the company, including the effectiveness of the Scheme, alteration of capital clause, fixing of record date, and share exchange ratio.